CELL INTELLIGENCE · 肿瘤细胞治疗研究

卵巢癌手术标本的标准化上游处理用于面向 TIL 的细胞工作流程

Standardized Upstream Processing of Ovarian Cancer Surgical Specimens for TIL-Oriented Cellular Workflows.

这些发现表明，即使输入材料高度可变，卵巢癌手术标本的标准化处理仍可生成适用于分离后质量评估的细胞悬液。

复发铂敏感上皮性卵巢癌患者化疗期间定时的过继性 T 细胞输注

Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer.

TIL 治疗可与铂类化疗安全联合，但不能与 IFNa 联合。

TIL（肿瘤浸润淋巴细胞）疗法联合 PD-1/LAG-3 抑制治疗复发性铂耐药卵巢癌患者

Tumor Infiltrating Lymphocyte Therapy Combined With PD-1/LAG-3 Inhibition in Patients With Recurrent Platinum-Resistant Ovarian Cancer.

表达人 vIL-2 细胞因子的溶瘤腺病毒改善 TIL（肿瘤浸润淋巴细胞）对晚期卵巢癌的细胞毒性应答

Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a hum

TIL（肿瘤浸润淋巴细胞）治疗能否改善晚期黑色素瘤患者的生存结局？

Does tumor-infiltrating lymphocyte therapy improve survival outcomes in patients with advanced melanoma?

乳腺癌与女性生殖道肿瘤中的 TIL（肿瘤浸润淋巴细胞）：被忽视的潜力与未探索的前沿

Tumor-Infiltrating Lymphocytes in Breast and Female Genital Tract Cancers: Overlooked Potential and Unexplored Frontiers.

基于 TIL 的疗法在个体化免疫治疗中显示出潜力，尤其是在复发、难治性卵巢癌中。对较罕见妇科肿瘤的研究有限，阻碍了更广泛的临床应用。